Aberdeen Group’s Pyxis Oncology PYXS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1M | Hold |
913,045
| – | – | ﹤0.01% | 829 |
|
|
2025
Q1 | $895K | Hold |
913,045
| – | – | ﹤0.01% | 826 |
|
|
2024
Q4 | $1.42M | Hold |
913,045
| – | – | ﹤0.01% | 791 |
|
|
2024
Q3 | $3.35M | Buy |
913,045
+204,742
| +29% | +$751K | 0.01% | 714 |
|
|
2024
Q2 | $2.34M | Hold |
708,303
| – | – | ﹤0.01% | 734 |
|
|
2024
Q1 | $3.02M | Hold |
708,303
| – | – | 0.01% | 737 |
|
|
2023
Q4 | $1.27M | Buy |
+708,303
| New | +$1.27M | ﹤0.01% | 818 |
|